Key Publications February 28, 2022

Lipoprotein(a) and benefit of PCSK9 inhibition in patients with nominally controlled LDL cholesterol.

J Am Coll Cardiol. 2021;78:421-433

Schwartz GG, Szarek M, Bittner VA, Diaz R, Goodman SG, Jukema JW, Landmesser U, López-Jaramillo P, Manvelian G, Pordy R, Scemama M, Sinnaeve PR, White HD, Gabriel Steg P, ODYSSEY Outcomes Committees and Investigators